Skip to main content
. 2023 Apr 25;28(7):2839–2847. doi: 10.1038/s41380-023-02067-2

Table 2.

Prospective, pediatric cohorts with repeated measures of methylation and/or imaging.

Cohort Age at baseline Years of follow-up DNAm (number of time points) MRI (number of time points) Sample sizea Reference
Generation R Birth 18 y Y (n = 5) Y (n = 4) Up to n = 9778 Kooijman et al. [83]
ALSPAC Birth 24 y Y (n = 7) Y (n = 1) Up to 15,458 Boyd et al. [84]
FinnBrain Birth 5 y Y (n = 1) Y (n = 2) Up to 3808 Karlsson et al. [85]
GUSTO Birth 3 y Y (n = 10) Y (n = 3) Up to 1176 Soh et al. [86]
DCHS Birth 6 y Y (n = 4) Y (n = 3) Up to 1143 Donald et al. [87]
NEURON Birth 2 y Y (n = 2) Y (n = 2) Up to 80 Moog et al. [88]
Fragile families Birth 15 y Y (n = 2) Y (n = 1) Up to 2020 Reichmann et al. [89]
Lifespan Baby Connectome Project (planned) Birth 5 y Y (n = 1) Y (n = 6) Up to 500 https://www.humanconnectome.org/study/lifespan-baby-connectome-project/overview
IMAGEN 14 y 8 y Y (n = 2) Y (n = 3) Up to 2463 Schumann et al. [90]
Brazilian High-Risk Cohort 6–14 y 6 y Y (n = 3) Y (n = 3) Up to 2512 Salum et al. [91]

aSample sizes refer to whole cohort, not limited to the subsample with DNAm or MRI.